Sengers Syndrome (MTDPS10)

External Ids:

Disease Ontology 12 DOID:0080132 OMIM 56 212350 OMIM Phenotypic Series 56 PS603041 MeSH 43 C538280 D002386 D009202 D028361 more MESH via Orphanet 44 C538280 ICD10 via Orphanet 33 Q87.8

UMLS via Orphanet 72 C1859317 Orphanet 58 ORPHA1369 MedGen 41 C1859317 SNOMED-CT via HPO 68 128306009 128602000 129565002 16851005 190882007 193570009 22066006 233873004 237950009 23986001 247053007 248268002 248274002 258211005 26544005 267044007 274524001 276617005 302215000 398151007 398152000 409623005 415116008 444896005 45227007 5587004 563001 57190000 59576002 609587005 79410001 84229001 91273001 more UMLS 71 C1859317

NIH Rare Diseases : ⁵² The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 1369 Definition Congenital cataract - hypertrophic cardiomyopathy - mitochrondrial myopathy (CCM) is a mitochondrial disease (see this term) characterized by cataracts, hypertrophic cardiomyopathy, muscle weakness and lactic acidosis after exercise. Epidemiology Prevalence of CCM is unknown; approximately 40 cases have been reported to date in disparate locations throughout the world. Clinical description Clinical features include congenital cataract (total or rapidly progressive), hypertrophic cardiomyopathy, muscle weakness and lactic acidosis after exercise. CCM may present in two forms, a neonatal lethal form or a chronic form. Hypertrophic cardiomyopathy is diagnosed at birth in half of the patients in both forms. Approximately half of the patients die within the first year of life due to cardiac failure. Nystagmus , strabismus , hypotonia , hyporeflexia and delayed motor development are occasional features. Marked lactic acidemia occurs with even limited muscular exertion. Patients who survive neonatal period and infancy, manifest the chronic form with stable cardiomyopathy and myopathy and have a normal intellect. Physical mobility is impaired due to muscular weakness in most patients. Etiology In the majority of CCM patients mutations (nonsense, frame-shift, start codon or splice site) in the AGK gene have been identified. The AGK gene encodes the mitochondrial acylglycerol kinase which plays a role in the assembly of adenine nucleotide translocator (ANT), an essential component of the oxidative phosphorylation in mitochondria . Two patients with distinct autosomal recessive SLC25A4 mutations have been reported (one of whom had cardiomyopathy but not cataract). The SLC25A4 gene encodes the heart and muscle specific isoform 1 of the mitochondrial ANT. The etiology remains genetically unsolved in the rest of cases of CCM. The milder affected individuals carried either splice site or start codon mutations. Diagnostic methods Diagnostic procedures include serum and urine analysis for lactic acid, radiology and echocardiogram for findings of cardiomyopathy. Muscle biopsy from cardiac and skeletal muscle reveals storage of lipid and glycogen, mitochondrial abnormalities, ANT deficiency and mild decrease of respiratory chain complexes I and IV. Genetic testing may reveal autosomal recessive mutations in AGK and SLC25A4 and it should be considered early in diagnostic workup. Differential diagnosis Differential diagnoses include mitochondrial encephalo-cardio-myopathy due to TMEM70 deficiency, isolated ATP synthase deficiency and Barth syndrome (see these terms). Antenatal diagnosis Prenatal genetic testing may be possible for families with affected children. Genetic counseling The reported mutations are transmitted in an autosomal recessive manner. Management and treatment CCM patients require cataract surgery during infancy and medical management of cardiomyopathy with standard therapy. Patients may require palliative care and a wheelchair for locomotion. Prognosis Approximately half of the reported patients die in the first year of life due to cardiac failure. The longest surviving patients are in their fifth decade of life. Visit the Orphanet disease page for more resources.

MalaCards based summary : Sengers Syndrome, also known as mitochondrial dna depletion syndrome 10, is related to encephalopathy, axonal, with necrotizing myopathy, cardiomyopathy, and cataracts and myopathy, myofibrillar, 2, and has symptoms including muscle weakness and fatigue. An important gene associated with Sengers Syndrome is AGK (Acylglycerol Kinase), and among its related pathways/superpathways is Mitochondrial protein import. Affiliated tissues include skeletal muscle, heart and testes, and related phenotypes are cataract and myopathy

Disease Ontology : ¹² A mitochondrial DNA depletion syndrome that is characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance, and lactic acidosis, but normal mental development, and has material basis in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the acylglycerol kinase gene on chromosome 7q34.

OMIM : ⁵⁶ Sengers syndrome is an autosomal recessive mitochondrial disorder characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance, and lactic acidosis. Mental development is normal, but affected individuals may die early from cardiomyopathy (summary by Mayr et al., 2012). Skeletal muscle biopsies of 2 affected individuals showed severe mtDNA depletion (Calvo et al., 2012). (212350)

UniProtKB/Swiss-Prot : ⁷³ Mitochondrial DNA depletion syndrome 10: An autosomal recessive mitochondrial disorder characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance, and lactic acidosis. Mental development is normal, but affected individuals may die early from cardiomyopathy.

Wikipedia : ⁷⁴ Sengers syndrome is a rare autosomal recessive condition characterised by congenital cataract,... more...

Clinical features from OMIM:

212350

Search Clinical Trials , NIH Clinical Center for Sengers Syndrome

Search GEO for disease gene expression data for Sengers Syndrome.